Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers


  Free Subscription

Articles published in Thorax

Retrieve available abstracts of 60 articles:
HTML format

Single Articles

    July 2021
  1. BIRKIN LJ, Vasileiou E, Stagg HR
    Citizen science in the time of COVID-19.
    Thorax. 2021;76:636-637.

  2. HOPKINSON NS, Rossi N, El-Sayed Moustafa J, Laverty AA, et al
    Current smoking and COVID-19 risk: results from a population symptom app in over 2.4 million people.
    Thorax. 2021;76:714-722.
    PubMed     Abstract available

    June 2021
  3. KANAI M, Kanai O, Tabuchi T, Mio T, et al
    Association of heated tobacco product use with tobacco use cessation in a Japanese workplace: a prospective study.
    Thorax. 2021;76:615-617.
    PubMed     Abstract available

  4. LOFFREDO L, Carnevale R, Battaglia S, Marti R, et al
    Impact of chronic use of heat-not-burn cigarettes on oxidative stress, endothelial dysfunction and platelet activation: the SUR-VAPES Chronic Study.
    Thorax. 2021;76:618-620.
    PubMed     Abstract available

  5. MASON SE, Moreta-Martinez R, Labaki WW, Strand M, et al
    Respiratory exacerbations are associated with muscle loss in current and former smokers.
    Thorax. 2021;76:554-560.
    PubMed     Abstract available

    March 2021
  6. FRANCIOSI AN, Carroll TP, McElvaney NG
    SZ alpha-1 antitrypsin deficiency and pulmonary disease: more like MZ, not like ZZ.
    Thorax. 2021;76:298-301.
    PubMed     Abstract available

    February 2021
  7. MAHON GM, Koppelman GH, Vonk JM
    Grandmaternal smoking, asthma and lung function in the offspring: the Lifelines cohort study.
    Thorax. 2021 Feb 4. pii: thoraxjnl-2020-215232.
    PubMed     Abstract available

    January 2021
  8. HOPKINS RJ, Duan F, Gamble GD, Chiles C, et al
    Chr15q25 genetic variant (rs16969968) independently confers risk of lung cancer, COPD and smoking intensity in a prospective study of high-risk smokers.
    Thorax. 2021 Jan 8. pii: thoraxjnl-2020-214839.
    PubMed     Abstract available

  9. LAVERTY AA, Millett C, Hopkinson NS, Filippidis FT, et al
    Introduction of standardised packaging and availability of illicit cigarettes: a difference-in-difference analysis of European Union survey data 2015-2018.
    Thorax. 2021;76:89-91.
    PubMed     Abstract available

    December 2020
  10. BARKER A, Cranwell J, Fitzpatrick I, Whittamore K, et al
    Tobacco and tobacco branding in films most popular in the UK from 2009 to 2017.
    Thorax. 2020;75:1103-1108.
    PubMed     Abstract available

    August 2020
  11. HORSFALL LJ, Burgess S, Hall I, Nazareth I, et al
    Genetically raised serum bilirubin levels and lung cancer: a cohort study and Mendelian randomisation using UK Biobank.
    Thorax. 2020 Aug 27. pii: thoraxjnl-2020-214756.
    PubMed     Abstract available

  12. O'CARROLL O, Sharma K, Fabre A, Murphy DJ, et al
    Vaping-associated lung injury.
    Thorax. 2020;75:706-707.

    July 2020
  13. LEBRETT MB, Balata H, Evison M, Colligan D, et al
    Analysis of lung cancer risk model (PLCOM2012 and LLPv2) performance in a community-based lung cancer screening programme.
    Thorax. 2020 Jul 6. pii: thoraxjnl-2020-214626.
    PubMed     Abstract available

    May 2020
  14. BALATA H, Harvey J, Barber PV, Colligan D, et al
    Spirometry performed as part of the Manchester community-based lung cancer screening programme detects a high prevalence of airflow obstruction in individuals without a prior diagnosis of COPD.
    Thorax. 2020 May 22. pii: thoraxjnl-2019-213584.
    PubMed     Abstract available

    April 2020
  15. PARK HY, Kang D, Shin SH, Yoo KH, et al
    Chronic obstructive pulmonary disease and lung cancer incidence in never smokers: a cohort study.
    Thorax. 2020 Apr 2. pii: thoraxjnl-2019-213732.
    PubMed     Abstract available

  16. NG C, Smyth AR
    Smoking ban in cars protects children, but is vaping 'The Elephant in the Car'?
    Thorax. 2020;75:297.

  17. KALRA SS, Pais F, Harman E, Urbine D, et al
    Rapid development of bullous lung disease: a complication of electronic cigarette use.
    Thorax. 2020;75:359.

  18. LAVERTY AA, Hone T, Vamos EP, Anyanwu PE, et al
    Impact of banning smoking in cars with children on exposure to second-hand smoke: a natural experiment in England and Scotland.
    Thorax. 2020;75:345-347.
    PubMed     Abstract available

    February 2020
  19. MILANZI EB, Koppelman GH, Smit HA, Wijga AH, et al
    Timing of secondhand smoke, pet, dampness or mould exposure and lung function in adolescence.
    Thorax. 2020;75:153-163.
    PubMed     Abstract available

    September 2019
  20. BALATA H, Tonge J, Barber PV, Colligan D, et al
    Attendees of Manchester's Lung Health Check pilot express a preference for community-based lung cancer screening.
    Thorax. 2019 Sep 3. pii: thoraxjnl-2018-212601.
    PubMed     Abstract available

    June 2019
  21. ZIELEN S, Fussbroich D
    Impact of secondhand smoke on cystic fibrosis: is there a link to fatty acid metabolism?
    Thorax. 2019;74:529-530.

  22. LAVERTY AA, Filippidis FT, Taylor-Robinson D, Millett C, et al
    Smoking uptake in UK children: analysis of the UK Millennium Cohort Study.
    Thorax. 2019;74:607-610.
    PubMed     Abstract available

    March 2019
  23. RAGHU VK, Zhao W, Pu J, Leader JK, et al
    Feasibility of lung cancer prediction from low-dose CT scan and smoking factors using causal models.
    Thorax. 2019 Mar 12. pii: thoraxjnl-2018-212638.
    PubMed     Abstract available

    February 2019
  24. BARCLAY ME, Lyratzopoulos G, Walter FM, Jefferies S, et al
    Incidence of second and higher order smoking-related primary cancers following lung cancer: a population-based cohort study.
    Thorax. 2019 Feb 18. pii: thoraxjnl-2018-212456.
    PubMed     Abstract available

    January 2019
  25. KOPP BT, Thompson R, Kim J, Konstan R, et al
    Secondhand smoke alters arachidonic acid metabolism and inflammation in infants and children with cystic fibrosis.
    Thorax. 2019 Jan 19. pii: thoraxjnl-2018-211845.
    PubMed     Abstract available

  26. EMERY JD, Murray SR, Walter FM, Martin A, et al
    The Chest Australia Trial: a randomised controlled trial of an intervention to increase consultation rates in smokers at risk of lung cancer.
    Thorax. 2019 Jan 10. pii: thoraxjnl-2018-212506.
    PubMed     Abstract available

    December 2018
  27. SCOTT A, Lugg ST, Aldridge K, Lewis KE, et al
    Pro-inflammatory effects of e-cigarette vapour condensate on human alveolar macrophages.
    Thorax. 2018;73:1161-1169.
    PubMed     Abstract available

    November 2018
  28. CROSBIE PA, Balata H, Evison M, Atack M, et al
    Second round results from the Manchester 'Lung Health Check' community-based targeted lung cancer screening pilot.
    Thorax. 2018 Nov 12. pii: thoraxjnl-2018-212547.
    PubMed     Abstract available

  29. BUTZ AM
    Implementing tobacco control policies for minority youth with second-hand smoke exposure and respiratory disease.
    Thorax. 2018;73:1004-1005.

  30. ASH SY, Harmouche R, Putman RK, Ross JC, et al
    Association between acute respiratory disease events and the MUC5B promoter polymorphism in smokers.
    Thorax. 2018;73:1071-1074.
    PubMed     Abstract available

    October 2018
  31. DIZIER MH, Margaritte-Jeannin P, Pain L, Sarnowski C, et al
    Interactive effect between ATPase-related genes and early-life tobacco smoke exposure on bronchial hyper-responsiveness detected in asthma-ascertained families.
    Thorax. 2018 Oct 3. pii: thoraxjnl-2018-211797.
    PubMed     Abstract available

  32. LOFFREDO L, Zicari AM, Occasi F, Perri L, et al
    Role of NADPH oxidase-2 and oxidative stress in children exposed to passive smoking.
    Thorax. 2018;73:986-988.
    PubMed     Abstract available

    September 2018
  33. SINGANAYAGAM A, Woodcock HV, Molyneaux PL, Jenkins G, et al
    Review of the British Thoracic Society Winter Meeting 2017, 6-8 December 2017, London, UK.
    Thorax. 2018;73:872-876.
    PubMed     Abstract available

  34. MORGAN AD, Rothnie KJ, Bhaskaran K, Smeeth L, et al
    Chronic obstructive pulmonary disease and the risk of 12 cardiovascular diseases: a population-based study using UK primary care data.
    Thorax. 2018;73:877-879.
    PubMed     Abstract available

    June 2018
  35. NEOPHYTOU AM, Oh SS, White MJ, Mak ACY, et al
    Secondhand smoke exposure and asthma outcomes among African-American and Latino children with asthma.
    Thorax. 2018 Jun 13. pii: thoraxjnl-2017-211383.
    PubMed     Abstract available

    May 2018
  36. MARKS GB
    Guiding policy to reduce the burden of COPD: the role of epidemiological research.
    Thorax. 2018;73:405-406.

  37. RONIT A, Lundgren J, Afzal S, Benfield T, et al
    Airflow limitation in people living with HIV and matched uninfected controls.
    Thorax. 2018;73:431-438.
    PubMed     Abstract available

  38. BHATT SP, Kim YI, Harrington KF, Hokanson JE, et al
    Smoking duration alone provides stronger risk estimates of chronic obstructive pulmonary disease than pack-years.
    Thorax. 2018;73:414-421.
    PubMed     Abstract available

    March 2018
  39. ANDUJAR P, Courbon D, Bizard E, Marcos E, et al
    Smoking, telomere length and lung function decline: a longitudinal population-based study.
    Thorax. 2018;73:283-285.
    PubMed     Abstract available

    February 2018
  40. CROSBIE PA, Balata H, Evison M, Atack M, et al
    Implementing lung cancer screening: baseline results from a community-based 'Lung Health Check' pilot in deprived areas of Manchester.
    Thorax. 2018 Feb 13. pii: thoraxjnl-2017-211377.
    PubMed     Abstract available

    December 2017
  41. BROWN SM, Wilson EL, Presson AP, Dinglas VD, et al
    Understanding patient outcomes after acute respiratory distress syndrome: identifying subtypes of physical, cognitive and mental health outcomes.
    Thorax. 2017;72:1094-1103.
    PubMed     Abstract available

  42. NUMAKURA T, Sugiura H, Akaike T, Ida T, et al
    Production of reactive persulfide species in chronic obstructive pulmonary disease.
    Thorax. 2017;72:1074-1083.
    PubMed     Abstract available

  43. QIU SL, Zhang H, Tang QY, Bai J, et al
    Neutrophil extracellular traps induced by cigarette smoke activate plasmacytoid dendritic cells.
    Thorax. 2017;72:1084-1093.
    PubMed     Abstract available

    November 2017
  44. HJELMBORG J, Korhonen T, Holst K, Skytthe A, et al
    Lung cancer, genetic predisposition and smoking: the Nordic Twin Study of Cancer.
    Thorax. 2017;72:1021-1027.
    PubMed     Abstract available

  45. ALIF SM, Dharmage SC, Benke G, Dennekamp M, et al
    Occupational exposure to pesticides are associated with fixed airflow obstruction in middle-age.
    Thorax. 2017;72:990-997.
    PubMed     Abstract available

    October 2017
  46. VASSALLO R, Harari S, Tazi A
    Current understanding and management of pulmonary Langerhans cell histiocytosis.
    Thorax. 2017;72:937-945.
    PubMed     Abstract available

  47. KOTZ D, Viechtbauer W, Simpson CR, van Schayck OCP, et al
    Cardiovascular and neuropsychiatric risks of varenicline and bupropion in smokers with chronic obstructive pulmonary disease.
    Thorax. 2017;72:905-911.
    PubMed     Abstract available

    July 2017
  48. LOCOCO F, Cardillo G, Veronesi G
    Does a lung cancer screening programme promote smoking cessation?
    Thorax. 2017 Jul 26. pii: thoraxjnl-2017-210621.

  49. BRAIN K, Carter B, Lifford KJ, Burke O, et al
    Impact of low-dose CT screening on smoking cessation among high-risk participants in the UK Lung Cancer Screening Trial.
    Thorax. 2017 Jul 14. pii: thoraxjnl-2016-209690.
    PubMed     Abstract available

  50. BOJESEN SE, Timpson N, Relton C, Davey Smith G, et al
    AHRR (cg05575921) hypomethylation marks smoking behaviour, morbidity and mortality.
    Thorax. 2017;72:646-653.
    PubMed     Abstract available

    June 2017
  51. KALUZA J, Larsson SC, Orsini N, Linden A, et al
    Fruit and vegetable consumption and risk of COPD: a prospective cohort study of men.
    Thorax. 2017;72:500-509.
    PubMed     Abstract available

    April 2017
  52. PACI E, Puliti D, Lopes Pegna A, Carrozzi L, et al
    Mortality, survival and incidence rates in the ITALUNG randomised lung cancer screening trial.
    Thorax. 2017 Apr 4. pii: thoraxjnl-2016-209825.
    PubMed     Abstract available

  53. BROWN SM, Wilson E, Presson AP, Zhang C, et al
    Predictors of 6-month health utility outcomes in survivors of acute respiratory distress syndrome.
    Thorax. 2017;72:311-317.
    PubMed     Abstract available

    March 2017
  54. YOUSAF-KHAN U, van der Aalst C, de Jong PA, Heuvelmans M, et al
    Risk stratification based on screening history: the NELSON lung cancer screening study.
    Thorax. 2017 Mar 30. pii: thoraxjnl-2016-209892.
    PubMed     Abstract available

    February 2017
  55. SCIOSCIA G, Blanco I, Arismendi E, Burgos F, et al
    Different dyspnoea perception in COPD patients with frequent and infrequent exacerbations.
    Thorax. 2017;72:117-121.
    PubMed     Abstract available

  56. SIDDIQI K, Elsey H
    Supporting the urban poor to quit tobacco: adding years to lives.
    Thorax. 2017;72:105-106.

    May 2016
  57. FU SS, van Ryn M, Nelson D, Burgess DJ, et al
    Proactive tobacco treatment offering free nicotine replacement therapy and telephone counselling for socioeconomically disadvantaged smokers: a randomised clinical trial.
    Thorax. 2016;71:446-53.
    PubMed     Abstract available

  58. GOODWIN AT, Wall J, Rajaram S, Amsha K, et al
    Breathlessness in an ex-miner: an unusual consideration.
    Thorax. 2016;71:481-2.

    April 2016
  59. OELSNER EC, Carr JJ, Enright PL, Hoffman EA, et al
    Per cent emphysema is associated with respiratory and lung cancer mortality in the general population: a cohort study.
    Thorax. 2016 Apr 5. pii: thoraxjnl-2015-207822.
    PubMed     Abstract available

    February 2016
  60. FRIEDEMANN SMITH C, Whitaker KL, Winstanley K, Wardle J, et al
    Smokers are less likely than non-smokers to seek help for a lung cancer 'alarm' symptom.
    Thorax. 2016 Feb 24. pii: thoraxjnl-2015-208063.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Smoking is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.